Gastroenterology
Latest News
What’s new in the new jaundice guidelines?
The neurotoxic risk factors and corresponding thresholds are important.
From the Journals
Colorectal cancer: Younger patients fare worse
Genetic data also showed increased prevalence of certain mutations in early-onset patients.
Conference Coverage
ADA: Screen all with type 2 diabetes for fatty liver disease
The ADA now advises screening all adults with type 2 diabetes or prediabetes, particularly those with obesity or cardiometabolic risk factors or...
Latest News
SAFE algorithm detects liver disease in general population
Scoring system was developed and validated to detect clinically significant (greater than stage 2) fibrosis in patients with NAFLD in primary care...
From the Journals
AAP issues guidance on inguinal hernias
Among the findings is that laparoscopic surgery, which is increasingly popular for the hernias, is a safe and effective option.
Commentary
DDW 2023: Common GI conditions in primary care
Gastroenterologist Vivek Kaul reviews important new studies relevant to primary care.
Latest News
‘Exciting time for NASH’ with resmetirom phase 3 results
Two doses of resmetirom met the primary endpoints of NASH resolution and no worsening of fibrosis on liver biopsy.
Latest News
Should race and ethnicity be used in CRC recurrence risk algorithms?
Removing race from clinical risk predictions could lead to higher racial bias in model accuracy and less accurate estimation of risk in some...
Latest News
No link between PPIs and dementia in new study
PPI use was not linked to changes in overall cognitive test scores over time.
News
Race and ethnicity loom large in CRC screening
Disparities can be seen in everything from choice of test to bowel prep, according to a review.
Feature
After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricing
SmithRx, which bills itself as “next-generation pharmacy benefits management,” announced that it will offer Yusimry to its members at a discount...